Literature DB >> 24394840

SAMeTT(2)R(2) does not predict time in therapeutic range of the international normalized ratio in patients attending a high-quality anticoagulation clinic.

Jane Skov1, Else-Marie Bladbjerg2, Mustafa Vakur Bor2, Jørgen Gram2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24394840     DOI： 10.1378/chest.13-1897

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience.

Authors:  Akash Kataruka; Xiaowen Kong; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Gregory D Krol; Scott Kaatz; Michael W McNamara; James B Froehlich; Geoffrey D Barnes
Journal:  Vasc Med       Date:  2017-02-01       Impact factor: 3.239

2.  SAME-TT2R 2 score and vitamin K antagonist therapy.

Authors:  Viroj Wiwanitkit
Journal:  Intern Emerg Med       Date:  2014-06-08       Impact factor: 3.397

3.  Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.

Authors:  Yun Kyung Park; Mi Ji Lee; Jae Ha Kim; Suk Jae Kim; June Soo Kim; Soo-Youn Lee; Oh Young Bang
Journal:  J Stroke       Date:  2015-05-29       Impact factor: 6.967

4.  SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events.

Authors:  Fernando Pivatto Junior; Rafael Selbach Scheffel; Lucas Ries; Ricardo Roitman Wolkind; Roberta Marobin; Sabrina Sigal Barkan; Luís Carlos Amon; Andréia Biolo
Journal:  Arq Bras Cardiol       Date:  2017-04       Impact factor: 2.000

Review 5.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

6.  Low Performance of a Clinical-Genetic Model in the Estimation of Time in Therapeutic Range in Acenocoumarol-Adherent Patients with Nonvalvular Atrial Fibrillation: The Quality of Anticoagulation Challenge.

Authors:  Samantha Wasniewski; Luciano Consuegra-Sánchez; Pablo Conesa-Zamora; Luis García de Guadiana-Romualdo; Pablo Ramos-Ruiz; Marta Merelo-Nicolás; F Guillermo Clavel-Ruipérez; Begoña Alburquerque-González; Federico Soria-Arcos; Juan A Castillo-Moreno
Journal:  Biomed Res Int       Date:  2018-10-17       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.